Nipro Europe Group Companies is delighted to announce the successful acquisition of NephroFlow NV, a Belgian software company.


NephroFlow NV (Bruges, Belgium) focuses on the development of medical software packages for dialysis centers. Thanks to their close collaboration with customers, the Nephroflow team has created a unique software solution (also named NephroFlow®) that does more than simply collect procedural data. This software has become an integral part of the dialysis treatment process – from planning and preparation to patient monitoring and administration – in order to actively support nurses and nephrologists, as well as to facilitate the general management of patients in dialysis centers.

Almost 1 in every 4 dialysis treatments in Belgium uses NephroFlow software. This success is driven by NephroFlow’s proven ability to significantly save time for dialysis teams.


Nipro Europe Group Companies (Mechelen, Belgium) is the European representative office of Nipro Corporation, a Japanese manufacturer of medical devices, pharmaceuticals, and pharmaceutical packaging. Nipro is one of the world’s largest suppliers of medical devices to dialysis centers and has been developing software for dialysis centers and hospitals in Japan for several years.

Having the patients in mind

This acquisition is part of Nipro’s ongoing commitment to improve patient outcomes and quality of life, bringing affordable care to dialysis patients around the world. In time, the NephroFlow software package will connect to other Nipro products, further enhancing our customers’ ability to save time and focus on what really matters – their patients.
Tom Alexander, VP Marketing & Business Development
Tom Alexander


Questions or inquiries regarding this acquisition can be addressed to Mr. Tom Alexander, VP Marketing and Business Development (